Replies to post #633075 on NorthWest Biotherapeutics Inc (NWBO)

[QL300]

Read below and maybe you’ll keep quiet…..unless you think UCLA is lying.

A vaccine to treat glioblastoma called DCVax-L has been in development for several years. Linda Liau, MD, PhD, MBA, and a team of UCLA researchers were the first to investigate whether a patient’s own dendritic cells (a specialized type of immune cell) could be used to create a personalized treatment for the deadly cancer.

At UCLA, Dr. Liau and other researchers are now testing whether the vaccine would be more effective in combination with a PD-1 checkpoint inhibitor. Checkpoint inhibitors are a type of immunotherapy that work by blocking proteins that stop the immune system from attacking cancer cells. While the vaccine allows T-cells to get inside of the tumor, the checkpoint inhibitors may allow T-cells to be more functional and better attack the tumor cells.

“Because of the heterogeneity of glioblastoma, I don’t think there is going to be one drug or one treatment that is going to be effective for all patients. The future of glioblastoma treatments is going to be these combination approaches,” Dr. Liau says.

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers

[The Danish Dude]

Great bullshit hand Hygro. I call with a Royal straight flush.

[Dr Bala]

Fudster HyGro knows zilch about GBM. He was posting on the INDIGO trial a while back. The fudster's post can be safely ignored because it carries zero useful info. The fudster should learn some scientific facts about this trial before he can fud. Too late to fud effectively anyway after the publication of the JAMA data.

[Roman516]

HG, your typo correction
You mean, "UCLA keeps confirming that they are using ATL with DCVax-L.", IMO

[LearningEveryTrade]

Hygro, If Pepsi is HQ'd in New York and tells a bottler in California, hey, we're really far apart... use the formula we jointly created and make it there for logistical reasons. It's STILL PEPSI.

bonus: it proves it can be manufactured in many centers.

[extrooper]

win a defamation lawsuit, you must prove that:

Someone made a statement;
The statement was published;
The statement caused you injury;
The statement was false; and
The statement did not fall into a privileged category

You may see this brought up in court against you as the defendant HyGro

[biosectinvestor]

That is not what that paper is about or what it says.

Secondly, anyone can take an email message, modify it and or just create it and take an image of that and post it.

The fact is, the key details I gave you including the recent press release from UCLA all confirm that ATL-DC, also in the title of the Phase 3 JAMA paper (not DC-Vax-L) confirm that the two are in fact the same thing. The original spore grant was to extend the research using DCVax-L, and of course that is all that makes sense. Anyone questioning this need only go back to my previous answer in this thread, for all the other links.

You have nothing. Just false nonsense that you repeatedly spout and if it’s not this it is some other desperate nonsense. I am sorry for you that your short position is going to hell, but you need to learn how to incorporate real information into your research, not bogus crap.

[Idunno]

Boy was it fun reading the replies to you. Besides the replies I really liked, here is a good one, sincerely for you, and likely in your best interest (from Bio): “I am sorry for you that your short position is going to hell, but you need to learn how to incorporate real information into your research, not bogus crap.” I mean, we know you know, but, at some point, you can only do so much with social media. You do not seem to persuade anyone here. Did you accidentally persuade yourself???

The Genie is out.

I’m guessing some of the smaller HF’s face an existential threat here. Especially if, others, start to really buy.

It’s fun being a small fish, I guess, swimming with sharks. For a while.